This compound is an active pharmaceutical ingredient metabolite characterized by a quinazoline core linked to an indazole and a phenoxyacetic acid moiety. It is primarily supplied for research and pharmaceutical manufacturing applications.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 911417-62-4
Belumosudil
pharmaceutical raw material
EXP-3174
pharmaceutical raw material
Riociguat metabolite M3
pharmaceutical raw material
Afatinib N-oxide
pharmaceutical raw material
1-hydroxymidazolam
pharmaceutical raw material
N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine
pharmaceutical raw material
Terbinafine
pharmaceutical raw material
Gemigliptin
pharmaceutical raw material
2-[3-[4-(1H-indazol-5-ylamino)quinazolin-2-yl]phenoxy]acetic acid
UHUDLFMBGUWKOR-UHFFFAOYSA-N
C1=CC=C2C(=C1)C(=NC(=N2)C3=CC(=CC=C3)OCC(=O)O)NC4=CC5=C(C=C4)NN=C5